메뉴 건너뛰기




Volumn 199, Issue , 2015, Pages 163-169

DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages

Author keywords

Atherosclerosis; M2 macrophages; Priming; SDF 1; Sitagliptin

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DIPEPTIDYL PEPTIDASE IV; PLACEBO; SITAGLIPTIN; STROMAL CELL DERIVED FACTOR 1; APOLIPOPROTEIN E; CXCL12 PROTEIN, MOUSE; CXCR4 PROTEIN, MOUSE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; INCRETIN;

EID: 84941556825     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.07.044     Document Type: Article
Times cited : (65)

References (36)
  • 1
    • 84895529499 scopus 로고    scopus 로고
    • Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: A 2-year study evaluation
    • G. Derosa, P.D. Ragonesi, E. Fogari, A.F. Cicero, L. Bianchi, A. Bonaventura, and et al. Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: a 2-year study evaluation Fundam. Clin. Pharmacol. 28 2014 221 229
    • (2014) Fundam. Clin. Pharmacol. , vol.28 , pp. 221-229
    • Derosa, G.1    Ragonesi, P.D.2    Fogari, E.3    Cicero, A.F.4    Bianchi, L.5    Bonaventura, A.6
  • 2
    • 84881507403 scopus 로고    scopus 로고
    • Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice
    • M. Terasaki, M. Nagashima, K. Nohtomi, K. Kohashi, M. Tomoyasu, K. Sinmura, and et al. Preventive effect of dipeptidyl peptidase-4 inhibitor on atherosclerosis is mainly attributable to incretin's actions in nondiabetic and diabetic apolipoprotein E-null mice PLoS One 8 2013 e70933
    • (2013) PLoS One , vol.8 , pp. e70933
    • Terasaki, M.1    Nagashima, M.2    Nohtomi, K.3    Kohashi, K.4    Tomoyasu, M.5    Sinmura, K.6
  • 3
    • 81855222104 scopus 로고    scopus 로고
    • Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis
    • Z. Shah, T. Kampfrath, J.A. Deiuliis, J. Zhong, C. Pineda, Z. Ying, and et al. Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis Circulation 124 2011 2338 2349
    • (2011) Circulation , vol.124 , pp. 2338-2349
    • Shah, Z.1    Kampfrath, T.2    Deiuliis, J.A.3    Zhong, J.4    Pineda, C.5    Ying, Z.6
  • 4
    • 84862908699 scopus 로고    scopus 로고
    • A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice
    • J. Matsubara, S. Sugiyama, K. Sugamura, T. Nakamura, Y. Fujiwara, E. Akiyama, and et al. A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice J. Am. Coll. Cardiol. 59 2012 265 276
    • (2012) J. Am. Coll. Cardiol. , vol.59 , pp. 265-276
    • Matsubara, J.1    Sugiyama, S.2    Sugamura, K.3    Nakamura, T.4    Fujiwara, Y.5    Akiyama, E.6
  • 5
    • 80051785333 scopus 로고    scopus 로고
    • DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice
    • N.N. Ta, C.A. Schuyler, Y. Li, M.F. Lopes-Virella, and Y. Huang DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice J. Cardiovasc. Pharmacol. 58 2011 157 166
    • (2011) J. Cardiovasc. Pharmacol. , vol.58 , pp. 157-166
    • Ta, N.N.1    Schuyler, C.A.2    Li, Y.3    Lopes-Virella, M.F.4    Huang, Y.5
  • 6
    • 84874597960 scopus 로고    scopus 로고
    • Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice
    • N. Ervinna, T. Mita, E. Yasunari, K. Azuma, R. Tanaka, S. Fujimura, and et al. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice Endocrinology 154 2013 1260 1270
    • (2013) Endocrinology , vol.154 , pp. 1260-1270
    • Ervinna, N.1    Mita, T.2    Yasunari, E.3    Azuma, K.4    Tanaka, R.5    Fujimura, S.6
  • 7
    • 84871686739 scopus 로고    scopus 로고
    • GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice
    • N. Panjwani, E.E. Mulvihill, C. Longuet, B. Yusta, J.E. Campbell, T.J. Brown, and et al. GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice Endocrinology 154 2013 127 139
    • (2013) Endocrinology , vol.154 , pp. 127-139
    • Panjwani, N.1    Mulvihill, E.E.2    Longuet, C.3    Yusta, B.4    Campbell, J.E.5    Brown, T.J.6
  • 8
    • 84862010640 scopus 로고    scopus 로고
    • Upregulation of SDF-1 is associated with atherosclerosis lesions induced by LDL concentration polarization
    • D. Wei, G. Wang, C. Tang, J. Qiu, J. Zhao, H. Gregersen, and et al. Upregulation of SDF-1 is associated with atherosclerosis lesions induced by LDL concentration polarization Ann. Biomed. Eng. 40 2012 1018 1027
    • (2012) Ann. Biomed. Eng. , vol.40 , pp. 1018-1027
    • Wei, D.1    Wang, G.2    Tang, C.3    Qiu, J.4    Zhao, J.5    Gregersen, H.6
  • 9
    • 0033964318 scopus 로고    scopus 로고
    • The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques
    • S. Abi-Younes, A. Sauty, F. Mach, G.K. Sukhova, P. Libby, and A.D. Luster The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques Circ. Res. 86 2000 131 138
    • (2000) Circ. Res. , vol.86 , pp. 131-138
    • Abi-Younes, S.1    Sauty, A.2    Mach, F.3    Sukhova, G.K.4    Libby, P.5    Luster, A.D.6
  • 10
    • 84897943212 scopus 로고    scopus 로고
    • Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis
    • E. Shantsila, L.D. Tapp, B.J. Wrigley, B. Pamukcu, S. Apostolakis, S. Montoro-Garcia, and et al. Monocyte subsets in coronary artery disease and their associations with markers of inflammation and fibrinolysis Atherosclerosis 234 2014 4 10
    • (2014) Atherosclerosis , vol.234 , pp. 4-10
    • Shantsila, E.1    Tapp, L.D.2    Wrigley, B.J.3    Pamukcu, B.4    Apostolakis, S.5    Montoro-Garcia, S.6
  • 11
    • 84898017437 scopus 로고    scopus 로고
    • Atorvastatin inhibits CXCR7 induction to reduce macrophage migration
    • W. Ma, Y. Liu, C. Wang, L. Zhang, L. Crocker, and J. Shen Atorvastatin inhibits CXCR7 induction to reduce macrophage migration Biochem. Pharmacol. 89 2014 99 108
    • (2014) Biochem. Pharmacol. , vol.89 , pp. 99-108
    • Ma, W.1    Liu, Y.2    Wang, C.3    Zhang, L.4    Crocker, L.5    Shen, J.6
  • 13
    • 84901467299 scopus 로고    scopus 로고
    • Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct
    • U.M. Gundra, N.M. Girgis, D. Ruckerl, S. Jenkins, L.N. Ward, Z.D. Kurtz, and et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct Blood 123 2014 e110 e122
    • (2014) Blood , vol.123 , pp. e110-e122
    • Gundra, U.M.1    Girgis, N.M.2    Ruckerl, D.3    Jenkins, S.4    Ward, L.N.5    Kurtz, Z.D.6
  • 14
    • 70349581878 scopus 로고    scopus 로고
    • Macrophage diversity and polarization in atherosclerosis: A question of balance
    • A. Mantovani, C. Garlanda, and M. Locati Macrophage diversity and polarization in atherosclerosis: a question of balance Arterioscler. Thromb. Vasc. Biol. 29 2009 1419 1423
    • (2009) Arterioscler. Thromb. Vasc. Biol. , vol.29 , pp. 1419-1423
    • Mantovani, A.1    Garlanda, C.2    Locati, M.3
  • 16
    • 84879083969 scopus 로고    scopus 로고
    • Phenotypic polarization of macrophages in atherosclerosis
    • N. Leitinger, and I.G. Schulman Phenotypic polarization of macrophages in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 33 2013 1120 1126
    • (2013) Arterioscler. Thromb. Vasc. Biol. , vol.33 , pp. 1120-1126
    • Leitinger, N.1    Schulman, I.G.2
  • 17
    • 84886284739 scopus 로고    scopus 로고
    • Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction
    • H.D. Theiss, L. Gross, M. Vallaster, R. David, S. Brunner, C. Brenner, and et al. Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction Int. J. Cardiol. 168 2013 3359 3369
    • (2013) Int. J. Cardiol. , vol.168 , pp. 3359-3369
    • Theiss, H.D.1    Gross, L.2    Vallaster, M.3    David, R.4    Brunner, S.5    Brenner, C.6
  • 18
    • 80052661942 scopus 로고    scopus 로고
    • Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis
    • H.D. Theiss, M. Vallaster, C. Rischpler, L. Krieg, M.M. Zaruba, S. Brunner, and et al. Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis Stem Cell Res. 7 2011 244 255
    • (2011) Stem Cell Res. , vol.7 , pp. 244-255
    • Theiss, H.D.1    Vallaster, M.2    Rischpler, C.3    Krieg, L.4    Zaruba, M.M.5    Brunner, S.6
  • 20
    • 0025215247 scopus 로고
    • Power and sample size calculations. A review and computer program
    • W.D. Dupont, and W.D. Plummer Jr. Power and sample size calculations. A review and computer program Control. Clin. Trials 11 1990 116 128
    • (1990) Control. Clin. Trials , vol.11 , pp. 116-128
    • Dupont, W.D.1    Plummer, W.D.2
  • 21
    • 4043117769 scopus 로고    scopus 로고
    • Modulation of hematopoietic stem cell homing and engraftment by CD26
    • K.W. Christopherson 2nd, G. Hangoc, C.R. Mantel, and H.E. Broxmeyer Modulation of hematopoietic stem cell homing and engraftment by CD26 Science 305 2004 1000 1003
    • (2004) Science , vol.305 , pp. 1000-1003
    • Christopherson, K.W.1    Hangoc, G.2    Mantel, C.R.3    Broxmeyer, H.E.4
  • 22
    • 0033852128 scopus 로고    scopus 로고
    • Molecular characterization of dipeptidyl peptidase activity in serum: Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides
    • C. Durinx, A.M. Lambeir, E. Bosmans, J.B. Falmagne, R. Berghmans, A. Haemers, and et al. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides Eur. J. biochem./FEBS 267 2000 5608 5613
    • (2000) Eur. J. Biochem./FEBS , vol.267 , pp. 5608-5613
    • Durinx, C.1    Lambeir, A.M.2    Bosmans, E.3    Falmagne, J.B.4    Berghmans, R.5    Haemers, A.6
  • 23
    • 84909953094 scopus 로고    scopus 로고
    • Short-term inhibition of DPP-4 enhances endothelial regeneration after acute arterial injury via enhanced recruitment of circulating progenitor cells
    • C. Brenner, N. Krankel, S. Kuehlenthal, L. Israel, F. Remm, C. Fischer, and et al. Short-term inhibition of DPP-4 enhances endothelial regeneration after acute arterial injury via enhanced recruitment of circulating progenitor cells Int. J. Cardiol. 2014 10.1016/j.ijcard.2014.09.016
    • (2014) Int. J. Cardiol.
    • Brenner, C.1    Krankel, N.2    Kuehlenthal, S.3    Israel, L.4    Remm, F.5    Fischer, C.6
  • 25
    • 77958195997 scopus 로고    scopus 로고
    • The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: Possible role of stromal-derived factor-1alpha
    • G.P. Fadini, E. Boscaro, M. Albiero, L. Menegazzo, V. Frison, S. de Kreutzenberg, and et al. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha Diabetes Care 33 2010 1607 1609
    • (2010) Diabetes Care , vol.33 , pp. 1607-1609
    • Fadini, G.P.1    Boscaro, E.2    Albiero, M.3    Menegazzo, L.4    Frison, V.5    De Kreutzenberg, S.6
  • 26
    • 84893162958 scopus 로고    scopus 로고
    • The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms
    • Y. Zeng, C. Li, M. Guan, Z. Zheng, J. Li, W. Xu, and et al. The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms Cardiovasc. Diabetol. 13 2014 32
    • (2014) Cardiovasc. Diabetol. , vol.13 , pp. 32
    • Zeng, Y.1    Li, C.2    Guan, M.3    Zheng, Z.4    Li, J.5    Xu, W.6
  • 27
    • 26244463577 scopus 로고    scopus 로고
    • Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage
    • R. Virmani, F.D. Kolodgie, A.P. Burke, A.V. Finn, H.K. Gold, T.N. Tulenko, and et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage Arterioscler. Thromb. Vasc. Biol. 25 2005 2054 2061
    • (2005) Arterioscler. Thromb. Vasc. Biol. , vol.25 , pp. 2054-2061
    • Virmani, R.1    Kolodgie, F.D.2    Burke, A.P.3    Finn, A.V.4    Gold, H.K.5    Tulenko, T.N.6
  • 30
    • 84886797808 scopus 로고    scopus 로고
    • Macrophages in atherosclerosis: A dynamic balance
    • K.J. Moore, F.J. Sheedy, and E.A. Fisher Macrophages in atherosclerosis: a dynamic balance Nat. Rev. Immunol. 13 2013 709 721
    • (2013) Nat. Rev. Immunol. , vol.13 , pp. 709-721
    • Moore, K.J.1    Sheedy, F.J.2    Fisher, E.A.3
  • 31
    • 85044503444 scopus 로고    scopus 로고
    • Clinical significance of macrophage phenotypes in cardiovascular disease
    • H.J. Medbury, H. Williams, and J.P. Fletcher Clinical significance of macrophage phenotypes in cardiovascular disease Clin. transl. med. 3 2014 63
    • (2014) Clin. Transl. Med. , vol.3 , pp. 63
    • Medbury, H.J.1    Williams, H.2    Fletcher, J.P.3
  • 32
    • 85040657852 scopus 로고    scopus 로고
    • Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases
    • J. Yang, L. Zhang, C. Yu, X.F. Yang, and H. Wang Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases Biomark Res. 2 2014 1
    • (2014) Biomark Res. , vol.2 , pp. 1
    • Yang, J.1    Zhang, L.2    Yu, C.3    Yang, X.F.4    Wang, H.5
  • 33
    • 84879562515 scopus 로고    scopus 로고
    • Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection
    • (e00264-13)
    • M.J. Davis, T.M. Tsang, Y. Qiu, J.K. Dayrit, J.B. Freij, G.B. Huffnagle, and et al. Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection mBio 4 2013 (e00264-13)
    • (2013) MBio , vol.4
    • Davis, M.J.1    Tsang, T.M.2    Qiu, Y.3    Dayrit, J.K.4    Freij, J.B.5    Huffnagle, G.B.6
  • 34
    • 30444447501 scopus 로고    scopus 로고
    • Reverse cholesterol transport and cholesterol efflux in atherosclerosis
    • R. Ohashi, H. Mu, X. Wang, Q. Yao, and C. Chen Reverse cholesterol transport and cholesterol efflux in atherosclerosis QJM 98 2005 845 856
    • (2005) QJM , vol.98 , pp. 845-856
    • Ohashi, R.1    Mu, H.2    Wang, X.3    Yao, Q.4    Chen, C.5
  • 35
    • 84897403739 scopus 로고    scopus 로고
    • Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice
    • B. Hewing, S. Parathath, T. Barrett, W.K. Chung, Y.M. Astudillo, T. Hamada, and et al. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice Arterioscler. Thromb. Vasc. Biol. 34 2014 779 789
    • (2014) Arterioscler. Thromb. Vasc. Biol. , vol.34 , pp. 779-789
    • Hewing, B.1    Parathath, S.2    Barrett, T.3    Chung, W.K.4    Astudillo, Y.M.5    Hamada, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.